Refine
Year of publication
Document Type
- Preprint (567)
- Article (337)
- Part of a Book (1)
Has Fulltext
- yes (905)
Is part of the Bibliography
- no (905)
Keywords
- Heavy Ion Experiments (18)
- Hadron-Hadron scattering (experiments) (11)
- Heavy-ion collision (6)
- LHC (5)
- Hadron-Hadron Scattering (4)
- Quark-Gluon Plasma (4)
- ALICE experiment (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- Atmospheric science (2)
- Beauty production (2)
- Charm physics (2)
- Climate change (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Jets (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Quark Gluon Plasma (2)
- Single electrons (2)
- gallbladder cancer (2)
- gallbladder cancer xenografts (2)
- pp collisions (2)
- 16S rRNA sequencing (1)
- 17-AAG (1)
- ALICE (1)
- ALICE detector (1)
- Accelerators & Beams (1)
- Accelerators & storage rings (1)
- Acute coronary syndrome (1)
- Anti-nuclei (1)
- Atmospheric chemistry (1)
- Atomic & molecular beams (1)
- Atomic, Molecular & Optical (1)
- Atrial fibrillation (1)
- BFIS (1)
- Beam loss (1)
- COVID-19 (1)
- Cardiac troponin (1)
- Cell membranes (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charge-transfer collisions (1)
- Chemical composition (1)
- Circular accelerators (1)
- Clinical Trials and Observations (1)
- Clinical genetics (1)
- Collective Flow (1)
- Demolition emissions (1)
- Distributed software development (1)
- Electron-pion identification (1)
- Electronic transitions (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Equation of state (1)
- Fibre/foam sandwich radiator (1)
- GWAS (1)
- Geometrical modelling (1)
- Geometrisches Modellieren (1)
- Guanine nucleotide exchange factors (1)
- Guanosine triphosphatase (1)
- HSP90 inhibitors (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Heavy Ion Experiment (1)
- Heavy Quark Production (1)
- Heavy flavor production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Häusliche Gewalt (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- J/ϕ (1)
- Kollisionen schwerer Ionen (1)
- Library screening (1)
- Low & intermediate-energy accelerators (1)
- Luciferase (1)
- Lymphoid Neoplasia (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Monte Carlo (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Myocardial infarction (1)
- NMR spectroscopy (1)
- Neural network (1)
- Neutron stars (1)
- Objectoriented technology (1)
- Objektorientierte Technologie (1)
- PKD (1)
- PKD/IC (1)
- PM10 (1)
- PRRT2 (1)
- Particle Correlations and Fluctuations (1)
- Particle interactions (1)
- Partikel-Wechselwirkungen (1)
- Phosphorylation (1)
- Photon counting (1)
- Polizeieinsatz (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Proton–proton (1)
- Psychiatric disorders (1)
- QCD (1)
- QGP signals (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Rapidity Range (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Resolution Parameter (1)
- SARS-CoV-2 (1)
- Simulation (1)
- Size distribution (1)
- Small molecules (1)
- Software engineering (1)
- Softwaretechnik (1)
- Spin-down (1)
- Systematic Uncertainty (1)
- TR (1)
- Thermal evolution (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Trigger (1)
- Ultrafine particles (1)
- Urban aerosol (1)
- Vector Boson Production (1)
- Vesicles (1)
- WYE-354 (1)
- Xenon-based gas mixture (1)
- accessory proteins (1)
- antibodies (1)
- antiepileptic drugs (1)
- b-cell lymphomas (1)
- bendamustine (1)
- cell-free protein synthesis (1)
- chemotherapy regimen (1)
- chimeric antigen receptor t-cell therapy (1)
- chimeric antigen receptors (1)
- dE/dx (1)
- dileptons (1)
- familial infantile epilepsy (1)
- flow (1)
- geldanamycin (1)
- genetic generalized epilepsy (1)
- heavy ion collisions (1)
- heavy ion experiments (1)
- hematopoietic stem cell transplantation (1)
- hemiplegic migraine (1)
- intrinsically disordered region (1)
- lamotrigine (1)
- leukapheresis (1)
- levetiracetam (1)
- lymphoma (1)
- mTOR inhibitors (1)
- microbiome (1)
- nonstructural proteins (1)
- pancreatic cancer (1)
- pancreatic surgery (1)
- particle ratios (1)
- pharmacoresistance (1)
- phenotypic spectrum (1)
- postoperative complications (1)
- quark gluon plasma (1)
- rapamycin (1)
- relativistic (1)
- relativistische (1)
- rituximab (1)
- spectra (1)
- strangeness (1)
- structural proteins (1)
- valproic acid (1)
- x-ray techniques (1)
Institute
- Physik (883)
- Frankfurt Institute for Advanced Studies (FIAS) (811)
- Informatik (775)
- Medizin (10)
- Biowissenschaften (3)
- Georg-Speyer-Haus (3)
- Geowissenschaften / Geographie (3)
- Informatik und Mathematik (3)
- Biochemie und Chemie (2)
- Geowissenschaften (2)
Increased sympathetic noradrenergic signaling is crucially involved in fear and anxiety as defensive states. MicroRNAs regulate dynamic gene expression during synaptic plasticity and genetic variation of microRNAs modulating noradrenaline transporter gene (SLC6A2) expression may thus lead to altered central and peripheral processing of fear and anxiety. In silico prediction of microRNA regulation of SLC6A2 was confirmed by luciferase reporter assays and identified hsa-miR-579-3p as a regulating microRNA. The minor (T)-allele of rs2910931 (MAFcases = 0.431, MAFcontrols = 0.368) upstream of MIR579 was associated with panic disorder in patients (pallelic = 0.004, ncases = 506, ncontrols = 506) and with higher trait anxiety in healthy individuals (pASI = 0.029, pACQ = 0.047, n = 3112). Compared to the major (A)-allele, increased promoter activity was observed in luciferase reporter assays in vitro suggesting more effective MIR579 expression and SLC6A2 repression in vivo (p = 0.041). Healthy individuals carrying at least one (T)-allele showed a brain activation pattern suggesting increased defensive responding and sympathetic noradrenergic activation in midbrain and limbic areas during the extinction of conditioned fear. Panic disorder patients carrying two (T)-alleles showed elevated heart rates in an anxiety-provoking behavioral avoidance test (F(2, 270) = 5.47, p = 0.005). Fine-tuning of noradrenaline homeostasis by a MIR579 genetic variation modulated central and peripheral sympathetic noradrenergic activation during fear processing and anxiety. This study opens new perspectives on the role of microRNAs in the etiopathogenesis of anxiety disorders, particularly their cardiovascular symptoms and comorbidities.
Stimulation of renal collecting duct principal cells with antidiuretic hormone (arginine-vasopressin, AVP) results in inhibition of the small GTPase RhoA and the enrichment of the water channel aquaporin-2 (AQP2) in the plasma membrane. The membrane insertion facilitates water reabsorption from primary urine and fine-tuning of body water homeostasis. Rho guanine nucleotide exchange factors (GEFs) interact with RhoA, catalyze the exchange of GDP for GTP and thereby activate the GTPase. However, GEFs involved in the control of AQP2 in renal principal cells are unknown. The A-kinase anchoring protein, AKAP-Lbc, possesses GEF activity, specifically activates RhoA, and is expressed in primary renal inner medullary collecting duct principal (IMCD) cells. Through screening of 18,431 small molecules and synthesis of a focused library around one of the hits, we identified an inhibitor of the interaction of AKAP-Lbc and RhoA. This molecule, Scaff10-8, bound to RhoA, inhibited the AKAP-Lbc-mediated RhoA activation but did not interfere with RhoA activation through other GEFs or activities of other members of the Rho family of small GTPases, Rac1 and Cdc42. Scaff10-8 promoted the redistribution of AQP2 from intracellular vesicles to the periphery of IMCD cells. Thus, our data demonstrate an involvement of AKAP-Lbc-mediated RhoA activation in the control of AQP2 trafficking.
The electron-capture process was studied for Xe54+ colliding with H2 molecules at the internal gas target of the Experimental Storage Ring (ESR) at GSI, Darmstadt. Cross-section values for electron capture into excited projectile states were deduced from the observed emission cross section of Lyman radiation, being emitted by the hydrogenlike ions subsequent to the capture of a target electron. The ion beam energy range was varied between 5.5 and 30.9 MeV/u by applying the deceleration mode of the ESR. Thus, electron-capture data were recorded at the intermediate and, in particular, the low-collision-energy regime, well below the beam energy necessary to produce bare xenon ions. The obtained data are found to be in reasonable qualitative agreement with theoretical approaches, while a commonly applied empirical formula significantly overestimates the experimental findings.
Pathogenic variants in PRRT2, encoding the proline-rich transmembrane protein 2, have been associated with an evolving spectrum of paroxysmal neurologic disorders. Based on a cohort of children with PRRT2-related infantile epilepsy, this study aimed at delineating the broad clinical spectrum of PRRT2-associated phenotypes in these children and their relatives. Only a few recent larger cohort studies are on record and findings from single reports were not confirmed so far. We collected detailed genetic and phenotypic data of 40 previously unreported patients from 36 families. All patients had benign infantile epilepsy and harbored pathogenic variants in PRRT2 (core cohort). Clinical data of 62 family members were included, comprising a cohort of 102 individuals (extended cohort) with PRRT2-associated neurological disease. Additional phenotypes in the cohort of patients with benign sporadic and familial infantile epilepsy consist of movement disorders with paroxysmal kinesigenic dyskinesia in six patients, infantile-onset movement disorders in 2 of 40 individuals, and episodic ataxia after mild head trauma in one girl with bi-allelic variants in PRRT2. The same girl displayed a focal cortical dysplasia upon brain imaging. Familial hemiplegic migraine and migraine with aura were reported in nine families. A single individual developed epilepsy with continuous spikes and waves during sleep. In addition to known variants, we report the novel variant c.843G>T, p.(Trp281Cys) that co-segregated with benign infantile epilepsy and migraine in one family. Our study highlights the variability of clinical presentations of patients harboring pathogenic PRRT2 variants and expands the associated phenotypic spectrum.
The highly infectious disease COVID-19 caused by the Betacoronavirus SARS-CoV-2 poses a severe threat to humanity and demands the redirection of scientific efforts and criteria to organized research projects. The international COVID19-NMR consortium seeks to provide such new approaches by gathering scientific expertise worldwide. In particular, making available viral proteins and RNAs will pave the way to understanding the SARS-CoV-2 molecular components in detail. The research in COVID19-NMR and the resources provided through the consortium are fully disclosed to accelerate access and exploitation. NMR investigations of the viral molecular components are designated to provide the essential basis for further work, including macromolecular interaction studies and high-throughput drug screening. Here, we present the extensive catalog of a holistic SARS-CoV-2 protein preparation approach based on the consortium’s collective efforts. We provide protocols for the large-scale production of more than 80% of all SARS-CoV-2 proteins or essential parts of them. Several of the proteins were produced in more than one laboratory, demonstrating the high interoperability between NMR groups worldwide. For the majority of proteins, we can produce isotope-labeled samples of HSQC-grade. Together with several NMR chemical shift assignments made publicly available on covid19-nmr.com, we here provide highly valuable resources for the production of SARS-CoV-2 proteins in isotope-labeled form.